Yann LeCun, Bob Langer, Jens Nielsen and Fabian Theis Join Cellular Intelligence Scientific Advisory Board
7 Articles
7 Articles
Yann LeCun, Bob Langer, Jens Nielsen and Fabian Theis Join Cellular Intelligence Scientific Advisory Board
/PRNewswire/ -- Cellular Intelligence, the AI company building a universal foundation model of cell signaling, today announced that Yann LeCun, Robert "Bob"...
Moderna's Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson's drug
Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer and Turing Award-winning AI researcher Yann LeCun have joined its scientific advisory board, along with Jens Nielsen…
Yann Le Cun, one of the sponsors of artificial intelligence, joins the scientific council of Cellular Intelligence. It is a very promising company that develops a new form of artificial intelligence to study cells.
Cellular Intelligence incorporated Bob Langer and AI pioneer Yann LeCun into its advisory bodies as it seeks to create models capable of predicting the behavior of living cells. The startup also acquired the global rights of an experimental Parkinson's therapy and plans to turn its biological models into tools for pharmaceutical companies.
Moderna’s Bob Langer and Yann LeCun join Cellular Intelligence advisory board to advance AI in medicine
The advisory board's expertise could accelerate breakthroughs in AI-driven cell biology, potentially revolutionizing regenerative medicine. The post Moderna’s Bob Langer and Yann LeCun join Cellular Intelligence advisory board to advance AI in medicine appeared first on Crypto Briefing .
Moderna’s Bob Langer and AMI’s Yann LeCun Cellular Intelligence’s board, bringing AI into medicine
Cellular Intelligence is trying to build an AI model that can predict and eventually control how living cells behave, the same way AI models predict text or images, in hopes of making new medicines faster and cheaper to develop. The company took a step toward that goal Monday, announcing that Moderna co-founder Robert “Bob” Langer […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
